Social Security pays benefits for a medical condition that is expected to last for at least a year, or may result in death. Supplemental Security… Read More »Do you qualify for Social Security disability as a cancer patient? 5 tests
At a certain age, you might start to wonder if you should be stepping up your screening for cancer. And then you might start to… Read More »Cancer Screening Tests to Consider Throughout Life
*Update Aug. 30, 2017 - The FDA has approved the CAR-T therapy tisagenlecleucel for certain leukemia patients. News of an FDA advisory committee that has reviewed… Read More »‘Individualized’ Immune Cell Engineering Therapy for Cancer Clears First FDA Hurdle
A frequent question women ask Susan Harvey, M.D. about mammograms: “Can’t you make it so they don’t squeeze so hard?” Unfortunately, some discomfort is part… Read More »What should you think about before getting a mammogram?
“Prostate cancer mortality has been declining since prostate cancer screening started in 1995,” says William G. Nelson, M.D., Ph.D., director of the Sidney Kimmel Comprehensive… Read More »Should all prostate cancers be treated?
Prostate cancer is extremely common in the U.S. “It’s the most common life-threatening cancer in men, responsible for 26,000 deaths per year,” says William G.… Read More »How common is prostate cancer?
“PSA, or prostate specific antigen, is an enzyme that normally appears in the ejaculate or central reproduction but when there’s a cancer present, it leaks… Read More »What is PSA?
“If you look at the overall incidence of cancer in the U.S., 80% of all cancers are diagnosed in people older than 60, and 30% of… Read More »Why do recommendations for colon cancer and prostate cancer screening tend to start around age 50?
When doctors told Stefanie Joho that they had no options left, her sister scoured the internet to find "something" that could offer hope. She found… Read More »Stefanie Joho describes how she participated in a landmark clinical trial of immunotherapy
Breaking news today as, for the first time, a drug has been FDA-approved for cancer based on disease genetics rather than type. Developed from 30… Read More »Historic cancer drug approval has roots at Johns Hopkins and its Bloomberg~Kimmel Institute laboratories and clinics